Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PTGX
#1006
Protagonist Therapeutics, Inc. - Common Stock
131.2
7
USD
+0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.06%
Monthly Change
+16.34%
6 month change
+55.33%
Year Change
+74.72%
Previous Close
129.8
9
Open
131.2
7
Low
131.2
7
High
131.2
7
Volume
135
Markets
US Stock Market
Healthcare
Biotechnology
PTGX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
61.98 M
62.21 M
62.52 M
63.81 M
64.31 M
64.31 M
Valuation ratios
Enterprise value
2.86 B
3.27 B
4.04 B
5.44 B
6.58 B
8.83 B
Price to earnings ratio
62
75.71
102.2
-42.6
-58.23
-77.53
Price to sales ratio
15.07
17.1
20.54
120.66
97.79
130.2
Price to cash flow ratio
8.84
86.57
62.72
96.28
-59.91
-79.76
Price to book ratio
1.25
1.37
1.58
9.03
2.66
3.54
Enterprise value to EBITDA ratio
101.87
131.49
201.66
-34.71
-46.69
-62.63
Profitability ratios
Return on assets %
-0.02
-0.05
-0.06
-0.07
0.01
0.01
Return on equity %
-0.02
-0.05
-0.06
-0.07
0.01
0.01
Return on invested capital %
-33.79
-127.7
-140.65
-174.67
-21.4
-21.4
Gross margin %
100
100
100
100
100
100
Operating margin %
-68.18
-758.04
-985.17
-677.09
-6.47
-6.47
EBITDA margin %
-67.34
-752.56
-977.5
-672.03
-5.75
-5.75
Net margin %
-41.15
-626.96
-834.87
-596.8
6.71
6.71
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
17.26
16.97
13.05
12.71
17.76
17.76
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.01
0.01
0.01
0.08
0.08
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.99
-0.45
-0.03
-0.58
-0.69
-1.76
EBIT per share
-0.31
-0.66
-0.73
-0.79
-0.05
-2.23
EBITDA per share
-0.3
-0.66
-0.72
-0.79
-0.05
-2.21
Total debt per share
—
—
—
—
—
—
Cash per share
9.12
8.98
9.03
8.92
7.77
7.77
Net current asset value per share
9.62
9.49
9.2
9.09
8.7
8.7
Tangible book value per share
10.94
10.52
10.12
9.67
9.3
9.3
Working capital per share
9.06
8.93
8.49
8.37
8.21
8.21
Book value per share
10.94
10.52
10.12
9.67
9.3
9.3
News
Best Momentum Stocks to Buy for July 13th
New Strong Buy Stocks for July 13th
New Strong Buy Stocks for July 9th
Protagonist Therapeutics (PTGX) Surges 7.1%: Is This an Indication of Further Gains?
Strength Seen in Agios Pharmaceuticals (AGIO): Can Its 17.7% Jump Turn into More Strength?
PTGX Stock Surges 64% in Six Months: What Is Driving the Rally?
J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It (NYSEARCA:XLV)
J&J Stock Down 3% in 3 Months: Is the Dip a Buying Opportunity?
Protagonist Therapeutics: A Royalty-Driven Biotech With Two Shots On Goal (NASDAQ:PTGX)
JNJ and AZN Face Patent Headwinds: Which Stock Looks Stronger Now?
J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?